StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)

Close on Nov 18, 2026Market cap $231.62MP/E –Yield –

Rocket Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Rocket Pharmaceuticals's pe ratio was 13.8× on Jan 31, 2018.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 201813.8×+6.2
2017Dec 29, 20177.6×–

More Rocket Pharmaceuticals figures

See a number that looks wrong?